Evolent Health (EVH) Reports In-Line Q2 EPS

Evolent Health (NYSE: EVH) reported Q2 EPS of ($0.13), in-line with the analyst estimate of ($0.13). Revenue for the quarter came in at $107.3 million versus the consensus estimate of $104.45 million.

For earnings history and earnings-related data on Evolent Health (EVH) click here.

You May Also Be Interested In

• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
• UBS Reiterates Buy Rating on General Motors (GM) as Defense Opportunity in Focus
• Piper Sandler on Fervo Energy (FRVO): 'Capital Access Supports Potential Upside'